Baker Bros. Advisors’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Baker Bros. Advisors’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,310	Closed	-$1.1M	–	135
2016 Q4	$1.1M	Hold	30,310	–	–	0.01%	104
2016 Q3	$1.16M	Buy	+30,310	New	+$448K	0.01%	106

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Baker Bros. Advisors's CLCD Position: Q1 2017 in Review

Baker Bros. Advisors sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 30,310 shares — an estimated $1.1M sold.

Baker Bros. Advisors first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $1.16M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Baker Bros. Advisors reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Baker Bros. Advisors sold 30,310 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.1M.
Baker Bros. Advisors first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Baker Bros. Advisors's CoLucid Pharmaceuticals, Inc. position peaked at $1.16M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Baker Bros. Advisors's 13F filing for Q1 2017, filed 15 May 2017.